Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Combating COVID: Eli Lilly accelerating baricitinib availability in India

Ruchika Sharma6 May 2021 12:00 PM IST

Indianapolis: Eli Lilly and Company has recently announced new initiatives to help COVID-19 patients in India as part of its commitment to...

Alembic Pharma gets USFDA nod for Dorzolamide Hydrochloride, Timolol Maleate Ophthalmic Solution to treat glaucoma

Ruchika Sharma6 May 2021 11:00 AM IST

Vadodara: Drug major, Alembic Pharmaceuticals Limited, has recently announced that the company has received final approval from the US Food & Drug...

Bajaj Healthcare launches COVID drug favipiravir under brand name Favijaj in India

Ruchika Sharma5 May 2021 11:50 AM IST

New Delhi: Drug firm Bajaj Healthcare on Tuesday announced the launch of its antiviral Favipiravir tablets under the brand name ''Favijaj'' used for...

Serum Institute to invest 240 million pounds for expansion in UK

Ruchika Sharma5 May 2021 10:00 AM IST

London: The Serum Institute of India will invest 240 million pounds in the UK to expand its vaccine business and set up a new sales office creating a...

Delhi HC asks CDSCO, Cipla to reply on PIL seeking to allow all Remdesivir makers to sell in domestic market

Ruchika Sharma4 May 2021 3:24 PM IST

The petition has also said that huge stocks of the medicine are lying at the ports for being exported and the same can be sold in the domestic market.

Serum Institute validates getting Rs 1732 crore from Govt for 11 crore Covishield doses

Ruchika Sharma4 May 2021 12:45 PM IST

New Delhi: Serum Institute of India (SII) on Monday endorsed the government statement that 100 per cent advance of Rs 1,732.50 crore has been released...

Delhi HC Restrains Use of CALDIMUST Trademark Deceptively Similar to Mankinds CALCIMUST

Mankind Pharma, Accenture collaborate to accelerate drugmaker's digital transformation

Ruchika Sharma4 May 2021 12:00 PM IST

New Delhi: Mankind Pharma, the fourth largest pharmaceutical manufacturing company headquartered in India, has collaborated with Accenture to...

Natco Pharma gets CDSCO emergency use nod for Baricitinib for treating COVID

Ruchika Sharma3 May 2021 1:31 PM IST

Hyderabad: Pharma major, Natco Pharma Limited, announced that the company has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and...

Glenmark Ryaltris-AZ launched at breakthrough price of Rs 175 per pack in India

Ruchika Sharma3 May 2021 11:50 AM IST

Ryaltris-AZ nasal spray relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and...

Serum Institute CEO says Covishield production in full swing in Pune

Ruchika Sharma3 May 2021 11:00 AM IST

New Delhi: Serum Institute of India CEO Adar Poonawalla has said that the production of COVID-19 vaccine Covishield is in full swing in Pune and he...

First consignment of 1.5 lakh Russian Sputnik V doses reach India

Ruchika Sharma3 May 2021 10:00 AM IST

New Delhi: India on Saturday received the first consignment of 1.5 lakh doses of Sputnik V COVID-19 vaccine from Russia as the country embarked on the...

Amid covid surge, Govt facilitates speedy imports of key medical devices

Ruchika Sharma2 May 2021 11:30 AM IST

The government has allowed this flexibility for labelling the essential medical devices post custom clearance but before sale for making the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok